Using two murine models of metastatic triple-negative breast cancer (TNBC) differing in their genetic alterations, we investigated the impact of leptin signaling on breast cancer metastasis under physiological (5 mM) glucose conditions. The gene discussed is LEP; the disease is breast carcinoma.